Your browser doesn't support javascript.
loading
[Ectopic hormonal syndrome].
Mihara, Masatomo; Hirata, Yukio.
Afiliación
  • Mihara M; Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School.
Gan To Kagaku Ryoho ; 37(6): 989-94, 2010 Jun.
Article en Ja | MEDLINE | ID: mdl-20567099
Ectopic hormonal syndrome, the most common cause of paraneoplastic syndrome, is due to an inappropriate secretion of peptide hormones by neoplasms derived from non-endocrine tissue, often discovered even by an occult neoplasm. The diagnosis of ectopic hormonal syndrome is established based on the following criteria;1. abnormal clinical signs and symptoms and/or inappropriate hormonal secretion associated with tumors;2. the abnormal endocrine syndrome and hormone secretion are reversed by tumor resection, and relapsed after tumor recurrence; 3. an arteriovenous gradient for the hormone across the tumor; and 4. the hormone can be detected in the tumor tissue. The treatment of choice for ectopic hormonal syndrome is directed at the primary tumor by surgical resection, radiotherapy, or chemotherapy, and the palliative treatment to control excess hormone secretion is effective in alleviation of symptoms.
Asunto(s)
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Paraneoplásicos Endocrinos Tipo de estudio: Etiology_studies Límite: Humans Idioma: Ja Revista: Gan To Kagaku Ryoho Año: 2010 Tipo del documento: Article
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Paraneoplásicos Endocrinos Tipo de estudio: Etiology_studies Límite: Humans Idioma: Ja Revista: Gan To Kagaku Ryoho Año: 2010 Tipo del documento: Article